|
1
|
Liu GT: Pharmacological actions and
clinical use of Fructus schizandrae. Chin Med J.
102:740–749. 1989.
|
|
2
|
Choi YW, Takamatsu S, Khan SI, Srinivas
PV, Ferreira D, Zhao J and Khan IA: Schisandrene, a
dibenzocyclooctadiene lignan from Schisandra chinensis:
structure-antioxidant activity relationships of
dibenzocyclooctadiene lignans. J Nat Pros. 69:356–359. 2006.
|
|
3
|
Panossian A and Wikman G: Pharmacology of
Schisandra chinensis Bail: an overview of Russian research
and uses in medicine. J Ethnopharmacol. 118:183–212. 2008.
|
|
4
|
Lu Y and Chen DF: Analysis of
Schisandra chinensis and Schisandra sphenanthera. J
Chromatogr A. 1216:1980–1990. 2009.
|
|
5
|
Lee YJ, Shim JW, Lee YJ, Park YH, Lee HY,
Kim SD, Choi YW and Bae YS: Identification of a novel compound that
stimulates intracellular calcium increase and CXCL8 production in
human neutrophils from Schisandra chinensis. Biochem Biophys
Res Commun. 379:928–932. 2009.
|
|
6
|
Choi YW, Kim HJ, Park SS, Chung JH, Lee
HW, Oh SO, Kim BS, Kim JB, Chung HY, Yu BP, Kim CD and Yoon S:
Inhibition of endothelial cell adhesion by the new
anti-inflammatory agent alpha-iso-cubebene. Vascul Pharmacol.
51:215–224. 2009.
|
|
7
|
Lee YJ, Park SY, Kim SG, Park DJ, Kang JS,
Lee SJ, Yoon S, Kim YH, Bae YS and Choi YW: Identification of a
novel compound that inhibits iNOS and COX-2 expression in
LPS-stimulated macrophages from Schisandra chinensis.
Biochem Biophys Res Commun. 391:1687–1692. 2010.
|
|
8
|
Bosch FX, Ribes J, Díaz M and Cléries R:
Primary liver cancer: worldwide incidence and trends.
Gastroenterology. 127:S5–S16. 2004.
|
|
9
|
Adami A, Hunter D and Trichopoulos D:
Cancer of the liver and biliary tract. Textbook of Cancer
Epidemiology. 2nd edition. Oxford University Press; Oxford: pp.
308–332. 2008
|
|
10
|
El-Serag HB and Mason AC: Risk factors for
the rising rates of primary liver cancer in the United States. Arch
Intern Med. 160:3227–3230. 2000.
|
|
11
|
Bruix J and Sherman M: Management of
hepatocellular carcinoma. Hepatology. 42:1208–1236. 2005.
|
|
12
|
Thomas MB and Zhu AX: Hepatocellular
carcinoma: the need for progress. J Clin Oncol. 23:2892–2899.
2005.
|
|
13
|
Yim SY, Lee YJ, Lee YK, Jung SE, Kim HJ,
Kim JE, Kim HJ, Son BG, Park YH, Lee YG, Choi YW and Hwang DY:
Gomisin N isolated from Schisandra chinensis significantly
induces anti-proliferative and pro-apoptotic effects in hepatic
carcinoma. Mol Med Rep. 2:725–732. 2009.
|
|
14
|
Andree HA, Reutelingsperger CP, Hauptmann
R, Hemker HC, Hermens WT and Willems GM: Binding of vascular
anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J
Biol Chem. 265:4923–4928. 1990.
|
|
15
|
Casciola-Rosen L, Rosen A, Petri M and
Schlissel M: Surface blebs on apoptotic cells are sites of enhanced
procoagulant activity: implications for coagulation events and
antigenic spread in systemic lupus erythematosus. Proc Natl Acad
Sci USA. 93:1624–1629. 1996.
|
|
16
|
Mazumder S, Plesca D and Almasan A:
Caspase-3 activation is a critical determinant of genotoxic
stress-induced apoptosis. Methods Mol Biol. 414:13–21. 2008.
|
|
17
|
Tsujimoto Y: Role of Bcl-2 family proteins
in apoptosis: apoptosomes or mitochondria? Genes Cells. 3:697–707.
1998.
|
|
18
|
Tsujimoto Y and Shimizu S: Bcl-2 family:
life-or-death switch. FEBS Lett. 466:6–10. 2000.
|
|
19
|
McKay BC, Ljungman M and Rainbow AJ:
Potential roles for p53 in nucleotide excision repair.
Carcinogenesis. 20:1389–1396. 1999.
|
|
20
|
Zakaria Y, Rahmat A, Pihie AH, Abdullah NR
and Houghton PJ: Eurycomanone induce apoptosis in HepG2 cells via
up-regulation of p53. Cancer Cell Int. 9:162009.
|
|
21
|
Azzam HS, Goertz C, Fritts M and Jonas WB:
Natural products and chronic hepatitis C virus. Liver Int.
27:17–25. 2007.
|
|
22
|
Chiu PY, Mak DH and Poon MK: In vivo
antioxidant action of a lignan-enriched extract of
Schisandra fruit and an anthraquinone-containing extract of
Polygonum root in comparison with schisandrin B and emodin.
Planta Med. 68:951–956. 2002.
|
|
23
|
Ko KM: Schisandrin B protects against
tert-butylhydroperoxide induced cerebral toxicity by enhancing
glutathione antioxidant status in mouse brain. Mol Cell Biochem.
238:181–186. 2002.
|
|
24
|
Nakamura K, Yoshida M and Uchiwa H:
Down-regulation of melanin synthesis by a biphenyl derivative and
its mechanism. Pigment Cell Res. 16:494–500. 2003.
|
|
25
|
Panossian AG: Effects of heavy physical
exercise and adaptogens on nitric oxide content in human saliva.
Phytomedicine. 6:17–26. 1999.
|
|
26
|
Yim TK and Ko KM: Schisandrin B protects
against myocardial ischemia-reperfusion injury by enhancing
myocardial glutathione antioxidant status. Mol Cell Biochem.
196:151–156. 1999.
|
|
27
|
Baek MS, Kim JY and Myung SW: Metabolism
of dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene
dioxybiphenyl-2,2′-dicarboxylate (DDB) by human liver microsomes:
characterization of metabolic pathways and of cytochrome P450
isoforms involved. Drug Metab Dispos. 29:381–388. 2001.
|
|
28
|
Iwata H, Tezuka Y and Kadota S:
Identification and characterization of potent CYP3A4 inhibitors in
Schisandra fruit extract. Drug Metab Dispos. 32:1351–1358.
2004.
|
|
29
|
Chang HF, Lin YH, Chu CC, Wu SJ, Tsai YH
and Chao JC: Protective effects of Ginkgo biloba, Panax
ginseng, and Schizandra chinensis extract on liver
injury in rats. Am J Chin Med. 35:995–1009. 2007.
|
|
30
|
Ko KM, Ip SP, Poon MK, Wu SS, Che CT, Ng
KH and Kong YC: Effect of a lignan-enriched fructus schisandrae
extract on hepatic glutathione status in rats: protection against
carbon tetrachloride toxicity. Planta Med. 61:134–137. 1995.
|
|
31
|
Chen N, Chiu PY and Ko KM: Schisandrin B
enhances cerebral mitochondrial antioxidant status and structural
integrity, and protects against cerebral ischemia/reperfusion
injury in rats. Biol Pharm Bull. 31:1387–1391. 2008.
|
|
32
|
Kubo S, Ohkura Y, Mizoguchi Y,
Matsui-Yuasa I, Otani S, Morisawa S, Kinoshita H, Takeda S, Aburada
M and Hosoya E: Effect of Gomisin A (TJN-101) on liver
regeneration. Planta Med. 58:489–492. 1992.
|
|
33
|
He XG, Lian LZ and Lin LZ: Electrospray
high performance liquid chromatography-mass spectrometry in
phytochemical analysis of kava (Piper methysticum) extract.
Planta Med. 63:70–74. 1997.
|
|
34
|
Chen DF, Zhang SX, Kozuka M, Sun QZ, Feng
J, Wang Q, Mukainaka T, Nobukuni Y, Tokuda H, Nishino H, Wang HK,
Morris-Natschke SL and Lee KH: Interiotherins C and D, two new
lignans from Kadsura interior and antitumor-promoting effects of
related neolignans on Epstein-Barr virus activation. J Nat Prod.
65:1242–1245. 2002.
|
|
35
|
Yasukawa K, Ikeya Y, Mitsuhashi H, Iwasaki
M, Aburada M, Nakagawa S, Takeuchi M and Takido M: Gomisin A
inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in
two-stage carcinogenesis in mouse skin. Oncology. 49:68–71.
1992.
|
|
36
|
Nomura M, Nakachiyama M, Hida T, Ohtaki Y,
Sudo K, Aizawa T, Aburada M and Miyamoto KI: Gomisin A, a lignan
component of Schizandora fruits, inhibits development of
preneoplastic lesions in rat liver by
3′-methyl-4-dimethylamino-azobenzene. Cancer Lett. 76:11–18.
1994.
|
|
37
|
Ohtaki Y, Hida T, Hiramatsu K, Kanitani M,
Ohshima T, Nomura M, Wakita H, Aburada M and Miyamoto KI:
Deoxycholic acid as an endogenous risk factor for
hepatocarcinogenesis and effects of gomisin A, a lignan component
of Schizandra fruits. Anticancer Res. 16:751–755. 1996.
|
|
38
|
Wu MD, Huang RL, Kuo LM, Hung CC, Ong CW
and Kuo YH: The anti-HBsAg (human type B hepatitis, surface
antigen) and anti-HBeAg (human type B hepatitis, e antigen) C18
dibenzocyclooctadiene lignans from Kadsura matsudai and
Schizandra arisanensis. Chem Pharm Bull (Tokyo).
51:1233–1236. 2003.
|
|
39
|
Chen DF, Zhang SX, Xie L, Xie JX, Chen K,
Kashiwada Y, Zhou BN, Wang P, Cosentino LM and Lee KH: Anti-AIDS
agents-XXVI. Structure-activity correlations of gomisin-G-related
anti-HIV lignans from Kadsura interior and of related
synthetic analogues. Bioorg Med Chem. 5:1715–1723. 1997.
|
|
40
|
Lu H and Liu GT: Anti-oxidant activity of
dibenzocyclooctene lignans isolated from Schisandraceae. Planta
Med. 58:311–313. 1992.
|
|
41
|
Park JY, Lee SJ, Yun MR, Seo KW, Bae SS,
Park JW, Lee YJ, Shin WJ, Choi YW and Kim CD: Gomisin A from
Schisandra chinensis induces endothelium-dependent and
direct relaxation in rat thoracic aorta. Planta Med. 73:1537–1542.
2007.
|
|
42
|
Bursch W, Ellinger A, Gerner C, Fröhwein U
and Schulte-Hermann R: Programmed cell death (PCD): apoptosis,
autophagic PCD, or others? Ann NY Acad Sci. 926:1–12. 2000.
|
|
43
|
Schwartz LM, Smitho SW, Jones MEE and
Osborne BA: Do all programmed cell deaths occur via apoptosis? Proc
Natl Acad Sci USA. 90:980–984. 1993.
|
|
44
|
Homburg CH, de Haas M, von dem Borne AE,
Verhoeven AJ, Reutelingsperger CP and Roos D: Human neutrophils
lose their surface Fc gamma RIII and acquire Annexin V binding
sites during apoptosis in vitro. Blood. 85:532–540. 1995.
|
|
45
|
Koopman G, Reutelingsperger CP, Kuijten
GA, Keehnen RM, Pals ST and van Oers MH: Annexin V for flow
cytometric detection of phosphatidylserine expression on B cells
undergoing apoptosis. Blood. 84:1415–1420. 1994.
|
|
46
|
Apakama I, Robinson MC, Walter NM,
Charlton RG, Royds JA, Fuller CE, Neal DE and Hamdy FC: Bcl-2
overexpression combined with p53 accumulation correlates with
hormone refractory prostate cancer. Br J Urol. 74:1258–1262.
1996.
|
|
47
|
Joensuu H, Pylkkänen L and Toikkanen S:
Bcl-2 protein expression and long-term survival in breast cancer.
Am J Pathol. 145:1191–1198. 1994.
|
|
48
|
Baekelandt M, Holm R, Nesland JM, Tropé CG
and Kristensen GB: Expression of apoptosis-related proteins is an
independent determinant of patient prognosis in advanced ovarian
cancer. J Clin Oncol. 18:3745–3747. 2000.
|
|
49
|
Harima Y, Nagata K, Harima K, Oka A,
Ostapenko VV, Shikata N, Ohnishi T and Tanaka Y: Bax and bcl-2
protein expression following radiation therapy versus radiation
plus thermoradiotherapy in stage IIIB cervical carcinoma. Cancer.
88:132–138. 2000.
|
|
50
|
Ito T, Fujieda S, Tsuzuki H, Sunaga H, Fan
G, Sugimoto C, Fukuda M and Saito H: Decreased expression of bax is
correlated with poor prognosis in oral and oropharyngeal carcinoma.
Cancer Lett. 140:81–91. 1999.
|
|
51
|
Yin C, Knudson CM, Korsmeyer SJ and van
Dyke T: Bax suppresses tumorigenesis and stimulates apoptosis in
vivo. Nature. 385:637–640. 1997.
|
|
52
|
Fabregat I: Dysregulation of apoptosis in
hepatocellular carcinoma cells. World J Gastroenterol. 15:513–520.
2009.
|
|
53
|
McGill G and Fisher DE: Apoptosis in
tumorigenesis and cancer therapy. Front Bioscience. 2:D353–D379.
1997.
|
